Myovant Sciences and Pfizer announce US FDA acceptance of supplemental NDA for Myfembree EP News Bureau Jun 4, 2022 The US FDA set a target action date of 29th January, 2023 for this sNDA under the Prescription Drug User Fee Act (PDUFA)
